New treatments for leukemia based on individual tumor characteristics
ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies
This study is looking at the details of leukemia to help find the best treatments for patients by matching them with therapies that fit their specific cancer, and it involves teamwork among researchers to turn new findings into real-life treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10795817 on NIH RePORTER |
What this research studies
This research focuses on understanding the molecular basis of leukemia to improve treatment outcomes for patients. By characterizing individual tumors at a molecular level, the project aims to match patients with specific therapies that target their unique cancer profiles. The approach involves collaboration among various research groups to create a system that efficiently translates new discoveries into clinical trials. Patients may be enrolled in therapeutic protocols that align with their tumor's genetic and molecular features.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with leukemia who are seeking innovative treatment options.
Not a fit: Patients with non-leukemic conditions or those who do not have identifiable molecular aberrations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatments for leukemia patients.
How similar studies have performed: Other research has shown promising results in using molecular profiling to tailor cancer treatments, indicating a strong potential for success in this approach.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Byrd, John C. — University of Cincinnati
- Study coordinator: Byrd, John C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.